Despite a high P/E ratio, the company's recent earnings traj...
Despite a high P/E ratio, the company's recent earnings trajectory is less appealing compared to the market. Investors overlook limited growth, hoping for a business turnaround. However, disappointment may loom if the P/E aligns with recent growth rates. The company's three-year earnings trends aren't impacting its high P/E as expected.
Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment